The Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Protects Against Microglia-Mediated Neuronal Loss In Vitro
Neuroinflammation is a key feature of all neurodegenerative disorders, including Alzheimer’s disease, and is tightly regulated by epigenetic mechanisms. Among them, bromodomain and extraterminal domain (BET) proteins play a crucial role by recognizing acetylated histones and acting as transcriptiona...
Saved in:
| Main Authors: | Marta Matuszewska, Anna Wilkaniec, Magdalena Cieślik, Marcin Strawski, Grzegorz A. Czapski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/4/528 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation
by: Marta Matuszewska, et al.
Published: (2025-07-01) -
Editorial: 15 years of Frontiers in Cellular Neuroscience: the dual role of microglia in (neuro)inflammation
by: Antonio J. Herrera, et al.
Published: (2025-02-01) -
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
by: Dan Zou, et al.
Published: (2024-11-01) -
Phylogenomic analysis of bromodomain genes in cotton (Gossypium spp.) and their potential roles in abiotic stress tolerance
by: Muhammad Tayyab, et al.
Published: (2025-07-01) -
Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
by: Benjamin Bian, et al.
Published: (2017-03-01)